Genmab - Stock Price History | GMAB
Historical daily share price chart and data for Genmab since 2023 adjusted for splits. The latest closing stock price for Genmab as of February 03, 2023 is 38.26.
- The all-time high Genmab stock closing price was 48.72 on September 03, 2021.
- The Genmab 52-week high stock price is 47.50, which is 24.2% above the current share price.
- The Genmab 52-week low stock price is 26.19, which is 31.5% below the current share price.
- The average Genmab stock price for the last 52 weeks is 36.25.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Genmab Historical Annual Stock Price Data |
| Year |
Average Stock Price |
Year Open |
Year High |
Year Low |
Year Close |
Annual % Change |
| 2022 |
35.7757 |
39.6800 |
47.0600 |
26.8300 |
42.3800 |
7.13% |
| 2021 |
40.7422 |
40.7600 |
48.7200 |
30.9200 |
39.5600 |
-2.71% |
| 2020 |
30.8508 |
22.3000 |
40.7600 |
17.1500 |
40.6600 |
82.09% |
| 2019 |
20.8930 |
18.1000 |
24.1400 |
18.0200 |
22.3300 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$25.237B |
$1.349B |
|
Genmab A/S is a biotechnology company. It specializes in development of antibody therapeutics for the treatment of cancer. The company's product pipeline includes DARZALEX(R), Arzerra(R), tisotumab vedotin, enapotamab vedotin, HexaBody-DR5/DR5(R) and DuoBody-CD3xCD20 (R),which are in clinical stage. Genmab A/S is based in Copenhagen V, Denmark.
|
